Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ONE Study: nTregs Trial
NCT02371434Phase 2Completed
- Start
- Feb 2015
- Primary completion
- Nov 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Autologous regulatory T Cell Product in kidney transplant rejection. Started Feb 2015; status: completed.
02
Drugs
Autologous regulatory T Cell Product
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02371434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371434.